Upload
nayef
View
39
Download
0
Embed Size (px)
DESCRIPTION
Overview of stone management in Japan. The 10 th Catholic International Urology Symposium, 2008 14 June 2008 Catholic University, Seoul. Tetsuro Matsumoto, MD, PhD Department of Urology, University of Occupational and Environmental Health. Incidence and management of stone - PowerPoint PPT Presentation
Citation preview
UOEH urology
Overview of stone management in Japan
Tetsuro Matsumoto, MD, PhDDepartment of Urology, University of
Occupational and Environmental Health
The 10th Catholic International Urology Symposium, 200814 June 2008Catholic University, Seoul
UOEH urology
Incidence and management of stone diseases in Japan
Incidence rate of urinary stone in Japan( /100,000 population )
119.640.379.3Female
308.9116.9192.0Male
Incidence rate
(/year)Reccurence
First diagnosis
UOEH urology
2005
Incidence rate in whole life (Incidence/year x average life expectancy x 100)
1995
Male : 122.6/100,000×76.36×100= 9.4%
Female : 49.4/100,000×82.84×100= 4.1%
2005
Male : 192.0/100,000×78.53×100=15.1%
Female : 79.3/100,000×85.49×100= 6.8%
UOEH urology
Incidence rate of upper urinary tract stoneIncidence (/100,000)
Incidence after demographycal correction
MaleFemale Total
MaleFemale Total
UOEH urology
Chronological change of incidence rate classified by age
Male
Female
UOEH urology
(Every 10 years)
Incidence of upper urinary stone classified by age(First diagnosis/Recurrence)
(/100,000)
Male firstFemale firstMale recurrenceFemale recurrence
MaleFemale
First:Recurrence
UOEH urology
Constituent of upper urinary tract stone in Japam
Male Female
Ca stone
2005
Infection stone
Urate stone
Cystine
Others
Ca stone
Infection stone
Urate stone
Cystine
Others
UOEH urology
Male Female
Ca stone
Infection stone
Urate stone
Cystine
Ca stone
Infection stone
Urate stone
Cystine
2005
Constituent of lower urinary tract stone in Japan
UOEH urology
Chronological change of constituent of upper urinary tract stone classified by age
Male
Female
Ca stone
Struvite
UrateCystine
Others
UOEH urology
Past history and basic disease in patients Rate (%)
Family history 9.7
Hypertension 21.7
Diabetes 9.8
Hyperlipidemia 14.1
Osteoporosis 2.0
Rate (%)
Hyperuricemia
Hypercalciuria
Hyperuricuria
Hyperoxaluria
Hypocitruria
13.7
3.1
3.2
1.5
2.0
Basic disease
UOEH urology
History
2005
Management of stone diseases in Japan
ESWL only TUL onlyESWL
+TUL
Others Total
ESWL only
TUL only
ESWL + TUL
No.
(%)
UOEH urology
Chronological change of surgical management for upper urinary tract stones
Open surgery
TUL or PNL
ESWL(incl. combined)
% Surgical treatment
% No surgical treatment
UOEH urology
Japanese guidelines for the management of stone diseases Dec, 2002, JUA
Renal stone(1)<20mm; ESWL(2)>20mm or Staghorn; PNL with ESWL
Ureter stone (1) Proximal; ESWL Option: (TUL, PNL)
(2) Middle; TUL or ESWL(3) Distal; <10mm; ESWL
>10mm; TUL
UOEH urology
UOEH urology
Experience in our hospital
The UOEH urolithiasis guideline
Renal stones (1) 5 to 20mm; ESWL Option:(PNL or TUL) (2)20mm to 30mm ; ESWL with double-J stent Option:(PNL or TUL) (3)>30 mm; PNL (with ESWL) Option:(lithotomy)
Ureter stones (A) Proximal; ESWL Option:(TUL or PNL) (B) Middle; ESWL (C) Distal; (1) 5 to 10mm; ESWL (2)>10mm; TUL
UOEH urology
UOEH hospital
Number of new patients in Urology servicein outpatient clinic in UOEH hospital
Around 10% is stone diseases
0
500
1000
1500
2000
2500
他疾患結石患者
year
OthersStones
UOEH urology
UOEH hospital
Location of stones
050100150200250300350
膀胱結石尿管結石腎結石
year
BladderUreterKidney
UOEH urology
UOEH hospital
UOEH urology
Ureteral stone
2007 Guideline for the management of ureteral calculi (EAU, AUA)
Stone Passage Rate (Meta analysis) Spontaneous passage <5mm; 68% >5mm, <10mm; 47%
Medical treatment to increase passage (MET) Nifedipine (Ca channel blocker); 9% (not significant) -blocker; 29%(significant) Tamsulosin (20% increase)> Nifedipine (significant)
No. of patients received surgical management
050100150200250300350
経過観察手術患者
year
UOEH urology
No surgerySurgery
UOEH hospital
UOEH urology
For all index patients Standard; Bacteriuria should be treated. (IV) Blind basket catheter should not be performed. (IV)
For ureteral stones <10mm Option; Observation with periodic evaluation. (1A) Standard; Should be counseled on the risks of MET. (IV)
For ureteral stones >10mm Standard; Must be informed about active treatment modality. (IV) Recommendation; SWL and URS first-line treatment (1A-IV) Routine stenting is not recommended (III) Option; Stenting following uncomplicated URS is optional (1A) Percutaneous antegrade ureteroscopy is first-line treatment in selected patients (III) ; impact large stoen in upper ureter, combination with renal stone removal, ureteral stone after urinary diversion, failure of retrograde ureteral access.
Index PatientNonpregnant adultUnilateral noncystine/nonuric acid radiopaque stoneNormal contralateral renal functionHealthy patient
2007 Guideline for the management of ureteral calculi (EAU, AUA)
Surgical management
0
50
100
150
200
膀胱切石尿管切石腎盂切石膀胱砕石TULPNLESWL
year
UOEH urology
UOEH hospital
VesicolithotomyUreterolithotomyPyelolithotomyVesicolithotripsy
UOEH urology
Stone free rates for SWL and URS in the overall population
Overall population
Distal ureter Distal ureter <10mm Distal ureter >10mmMid ureter Mid ureter <10mm Mid ureter >10mmProximal ureter Proximal ureter <10mm Proximal ureter >10mm
SWL
74%86%74%73%84%76%82%90%68%
URS
94%97%93%86%91%78%81%80%79%
Statistics
significantsignificantsignificant
nsnsnsnsns
significant2007 Guideline for the management of ureteral calculi
(EAU, AUA)
Results of TUL ( 2005 ~ 2007 )
Cases Stone free rate
15 11( 73 %)
9 5( 56 %)
24 22( 91.6 %)
U1
U2
U3
UOEH hospital
UOEH urology
Conversion from ESWL to TUL
ESWL cases Conversion to TUL
82 7 (8.5%)
81 2 (2.4%)
60 4 (6.6%)
Total
2005
2006
2007
223 13 (5.8%)
UOEH hospital
UOEH urology
Patient; 61y, FemalePresent illness: Recurrent UTI for 3 years & Lt hydronephrosis due to Lt ureter stone (U1)
Past history; Kaiser ope 2 times. Ope for Abdominal wall hernia
Complication; Obese Ope scar
A case of problem stone
UOEH urology
22×12mm
DIP
CT
Impacted stone
UOEH urology
Option of management (U1;Impacted stone)
ESWL; High failure rate to impacted stone
TUL; Difficulty of keeping optical view or push up to kidney
PNL; Damage of Lt kidney
Operation performed; Retroperitoneoscopic ureterolithotomy
Retroperitoneoscopic ureterolithotomy
N ×
×
12mm port
5mm port×
Lt ureter
Ureterotomy Stone
2 weeks after ope 3 months after ope
Retroperitoneal laparoscopipc ureterolithotomy is one of option forlong-term impacted stone.
UOEH urology
Stone disease is infectious diseases?
UOEH urology
UTI and urinary stone are closely related.
Urinary stone induces UTI.
UTI causes urinary stone.
All kind of human diseases is closely related with infection?
Cancer: Uterine cervical cancer;Human papilloma virus Liver cancer; Hepatitis virus C Gastric cancer; Helicobacter pyroli Renal cancer; Virus?
Arteriosclerosis, Myocardial infarction; Chlamydophyla pneumoniaeMany kinds of autoimmune diseases, Collagen diseases Benign prostatic hyperplasia etc, etc
Urinary stone is also infectious disease?UOEH urology
UOEH urology
Stone diseases are infectious diseases?
1. Urea splitting enzyme producing-microorganism; Struvite stone
2. Nanobacteria; Apatite stone
3. Oxalobacter formigenes; Prevent stone formation due to diminish the absorption and excretion of oxalate
Urea splitting enzyme-producing bacteria causes struvite stone
UOEH urology
Many kinds of ureasplitting enzyme-producing bacteria;cause complicatedUTI.
GNR
GPC
Mycoplasma
Fungi
Microorganism Almost all producing Sometimes producing
UOEH urology
Urease –producing bacteria
While struvite stone is caused by UTI,
Apatite stone is also caused by infection?
UOEH urology
UOEH urology
NanobacteriaKajander & Ciftcioglu (Finnish researcher, PNAS 1998) -Putative cell-walled microorganism -Low diameter; 0.2m -Apparent culture -Partially characterized Ribosomal RNA -Isolated from human and cow blood -Microscopic mineral structure (Ca, P) =Biomineralization -Not culturable in irradiated blood
Nanobacteria ; Small, Gram negative Proteobacteria group Needle-shaped calcium apatite cell wall
UOEH urology
Nanobacteria; an infectious cause for kidney stone formation ; Ciftcioglu et al; Kidney Int 1999
SEM;70/72 (97.2%) stones were Nanobacteria positive.
UOEH urology
Nanobacteria; Controversial pathogens in nephrolithiasis and polycystic kidney disease.Kajander et al; Curr Opin Nephrol Hypertens 2001
Direct injection of nanobateria into kidney resulted in stone formation in rats and rabbits
UOEH urology
Nanobac Announces peer reviewed publication verifying self-propagating calcifying nanoparticles as a unique entityCNPs hypothesized to resemble prions
CAL-DETOX; EDTA Nanobac Pharmaceuticals Inc.
UOEH urology
UOEH urology
Controversial issue
Cisar J. (NIH, FDA group ; PNAS 2000) -Found same structure in same condition -rRNA=Phyllobacterium mysinacearum; contamination -Resistant to almost all antimicrbials and sodium azide -Non sensitive to heat and powerful respiratory inhibitor
Conclusion
Infection is quite interesting.UOEH urology